Programme 3rd Edition - The European partnering event for innovation partnerships and investment rounds in the MedTech, diagnostic and digital ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
3rd Edition
Programme
The European partnering event
for innovation partnerships and investment rounds
in the MedTech, diagnostic and digital health sectors
#MedFIT2019
@MEDFIT_EVENT
1 www.medfit-event.com MedFIT Event
Welcome
« Since its creation, MedFIT has become the first European partnering event dedicated
to innovation in the MedTech, diagnostic and digital health sectors.
MedFIT is your opportunity to connect with international Today, we are very pleased to welcome you to Lille for the third edition of MedFIT, where
key innovators in the MedTech, diagnostic and digital more than 700 international key players from over 25 countries are representing large
health sectors. As the leading European partnering event, companies, SMEs, start-ups, academic and technology transfer organisations, investors,
MedFIT provides the ideal environment for academic and and service companies.
industrial actors to build partnerships, to source innovative Thanks to the various MedFIT activities, we hope that you will find collaborative partners
and competitive early-stage R&D projects, to facilitate the and obtain funding.
emergence of collaborative projects, to increase licensing
opportunities, to obtain funding and to facilitate market access. We hope to see you next year in Grenoble on June 30th and July 1st, 2020 for the fourth
edition of MedFIT, where more meetings, deals and discoveries of innovative projects in
the MedTech, diagnostic and digital health sectors will take place.»
MedFIT 2019 key figures:
700+ delegates
Etienne Vervaecke
General Manager of Eurasanté and NHL Cluster
25+ countries represented
3,000+ meetings generated Marco Pintore
General Manager of BioValley France
80+ exhibitors
60+ speakers Grégory Vernier
Executive Director of MEDICALPS
50+ innovation pitchers
Institutional partners: With the support of: Organisers:
2 3
Organisers
www.eurasante.com @Eurasante
Eurasanté is an incubator, a technology transfer tool and a cluster manager in the biotech, medtech,
nutrition and healthcare fields in Northern France. It assists French and foreign companies,
entrepreneurs, scientists and clinicians with their innovations and development projects. The
regional network includes over 1,000 companies working in Life Sciences and Healthcare. The
Health field in the Hauts-de-France region has a total of 30,800 employees. Eurasanté also
promotes the Eurasanté Bio-business Park which hosts 7 hospitals, 4 universities, 7 specialised
schools, 170 companies and 50 laboratories. Eurasanté also organises four international healthcare-
related partnering events intended to increase and improve interaction between academia and
industry: BioFIT, NutrEvent, MedFIT and AgeingFit.
www.nhl-cluster.com @PoleNSL
The Nutrition Health Longevity (NHL) Cluster is a dynamic network at the intersection of health,
biotechnology and nutrition. The NHL Cluster aims to connect academia and industry partners
around R&D projects. It focuses on the prevention and treatment of lifestyle-related diseases,
such as metabolic and cardiovascular pathologies, neurodegenerative diseases and inflammatory
bowel diseases. Its goal is to bring together and support stakeholders from the health and food
sectors in designing, developing and financing their future products and processes.
Lille and the Hauts-de-France region,
www.biovalley-france.com @BioValleyFrance
a dynamic hub for MedTech in Europe
Competitiveness cluster since 2005, BioValley France aims to federate, develop and promote the
healthcare sector in the Grand Est region through innovation. The cluster is based on a dynamic
network of companies, a leading academic and clinical research, as well as an integrated network The MedTech sector in the Hauts-de-France region benefits from
of key stakeholders in innovation. BioValley France supports its members in their R&D Innovation the presence of both big players (Bio-Rad, Medtronic…) and of a
approach and gives them access to high value-added expertise, in a market approach. The Cluster dense network of SMEs. It is boosted by the Eurasanté Bio-incubator.
contributes to the networking of the various actors and the creation of regional, national and
international partnerships. Finally, BioValley France actively participates in the territory’s structuring
projects, such as Nextmed, which aims to create a Medical Technologies campus in Strasbourg The main areas of expertise in the Hauts-de-France region are implantable
that hosts an entire ecosystem of excellence dedicated to the development of tomorrow’s health medical devices, innovative textile, hospitech and diagnostic.
technologies.
The MedTech sector in the Hauts-de-France region (2018):
• 516 biomedical companies such as Macopharma, Diagast, Cousin Biotech,
www.medicalps.eu @medicalps MDMS, NewCard, Japet Medical Devices, Lattice Medical…
Founded in 2000, MEDICALPS is an NPO and a cluster of companies in the field of healthcare
• 8,885 employees
technologies. It is located in Grenoble, in the heart of the French Alps, known as one of the • €2.2 billion turnover
most inventive cities in the world and a top-notch place to innovate in the high-tech industry.
MEDICALPS gathers over 100 members including leading edge start-ups, SMEs, global players, • Research teams of excellence in the fields of biosensors, biomedical and
world-class research centres and universities. Although actively supported by local authorities, hospital engineering, nanotech applied to life sciences, biomaterials…
MEDICALPS is mainly governed by a community of entrepreneurs who aim to ensure the visibility,
growth and international development of member companies. With a unique emphasis on the • Academic institutions of excellence like the University Hospital of Lille,
healthcare technology sector, our objectives focus on: gathering stakeholders and promoting
the local ecosystem through communication tools and networking opportunities, facilitating
the University of Lille, the University of Compiègne…
member operations by setting up workshops, presence at exhibitions and conventions and a
soft-landing programme in US in addition to other services, structuring the local healthcare sector
by developing shared industrial resources.
4 5
Steering Committee Table of contents
Industry
Organisers 4
Steering Committee 6
Sponsors 9
Stig Visti Andersen Amanda Baccarini Leo Kretzers Daniel Kroiss Stéphane Lavallée MEDFIT AGENDA 12 12
CEO VP, Global Marketing
& Strategic Innovation
General Manager,
Bakken Research Center
VP Chief Scientific Officer
CRM
President
HOSTED EVENTS AGENDA 14 14
Magnisense Surgivisio
Becton Dickinson Medtronic LivaNova
Medical - Pharmaceutical Systems
ONE-TO-ONE MEETINGS 16
One-to-one meetings - Who will you meet? 16
Would-be CEO 18
Louis de Lillers
CEO
Antonin Marcault
New Business Development
Nicolas Ploquin
CEO
Cécile Réal
CEO
Nils Reimers
R&D Manager
MEET-THE-EXPERTS 20
CorWave and Innovation Manager Unilabs France Endodiag Stryker
Philips
PITCH SESSIONS 22
Academia, technology transfer offices Start-up Slams 23
Collaborative and Licensing Opportunity Presentations 26
Service Presentations 28
CONFERENCE PROGRAMME 30
Remke Burie Josephine Dixon-Hardy Caroline Dreyer PLENARY SESSION 31
Operations Director,
Technical Medical Centre
Director of Medical
Technology Innovation
President
SATT Conectus
TRACK 1 | Collaborate to Innovate 32
University of Twente University of Leeds
TRACK 2 | Financing Innovation 34
TRACK 3 | Market Innovation 36
TRACK 4 | Digital Innovation 38
Terry Gourlay Michel de Mathelin Abhay Pandit
HOSTED EVENTS 42
Head of Department,
Biomedical Engineering
Director Scientific Director
CURAM
EIT-Health 42
I-cube lab
University of Strathclyde SmartHealth 43
Investors Imode 44
CoBra 45
Derma 46
GHT Business Convention 47
Peer2Scale - Health 48
Frank Bulens James Greene Joseph Nathan 3DMed 49
Partner
Imec.xpand
Advisor
Seroba Lifesciences
Director New Ventures
Alfred Mann
Mat(t)isse 50
Institute at the Technion SMMiL-E / Yncréa 51
Associations, clusters & law firms
EXHIBITION 52
Exhibitor List & Floor Plan 52
Exhibitor Descriptions 54
Sponsors & Partners 70
Marco Pintore Florent Surugue Cécile Théard-Jallu Grégory Vernier Etienne Vervaecke
General Manager Economic Development Partner Attorney Executive Director General Manager
BioValley France and SMEs Director De Gaulle Fleurance & MEDICALPS Eurasanté & NHL Cluster
6 SNITEM Associés 7
Sponsors
Protecting innovation, enhancing value
Gold
Silver
European Patent
& Trade Mark Attorneys
Conseils en Propriété Industrielle Bronze
Sciences de la Vie, Chimie
et Dispositif Médical
Contributing
Image et création : Square & Martin’s Production
LYON PARIS BRUXELLES
www.icosa.fr
8 9
Running out of battery? CONNECTING TO THE WI-FI
Come to the partnering
desk to borrow a Choose the Wi-Fi named «LGP FREE»
power bank!
CONNECTING TO THE WIFI
Open a new webpage on your browser
Accept the terms of use
Demipagepub2019.pdf 1 15/05/2019 16:31:18
Download the «Inova Event» app 4 AREAS
OF EXCELLENCE
IMPLANTS &
PROSTHESES
MEDICAL / SURGICAL
EQUIPMENT
AND INSTRUMENTATION
ADVANCED THERAPY
MEDICINAL PRODUCTS
COMBINED
MEDICAL
DEVICES
to receive your agenda updates HEALTHCARE INNOVATION
Organise your agenda | Request and manage meetings | Mobile messaging YOUR ECOSYSTEM
C
> 245 COMPANIES - > TRANSFER AND PROMOTION > SEARCH OF EXCELLENCE
M INNOV’HEALTH CLUSTER BIOINNOVATION: new Femto-ST Institute (UMR - CNRS): Biom@x,
J
Visibility & networking product developement microsystems, proteomics, micro-robotics,
Expertise & proficiency: center - 4,000m² biomechanics, e-health, optics
CM regulatory affairs, expert Clinical Investigation Center Institute of Cellular and Tissue Bioengineering
groups, training (Inserm) (UMR - Inserm): Advanced therapy medicinal
Business French Blood Establishment products, Clinical Bioproduction
MJ
© Temis / Grand Besançon - Emmanuel EME / Adobe stock
Accelerator SATT SAYENS
CJ
> TRANSDISCIPLINARY TRAINING
Conception graphique : Pôle des Microtechniques
CMJ
> TEMIS TECHNOPOLE > LEADING INNOVATION ISIFC: Institute of Medical Device Engineers
Innovation park (250 ha) 75 labeled projects Medicine - Pharmacy university department
N
Business incubator and Artificial pancreas, smart (5,900 students)
business hotel valves, artificial larynx, ENSMM: mechanics, microtechnology and design
Land & dedicated property innovative cancer treatments...
Project engineering
MEET US AT
STAND C1
www.temis.org
10 www.pmt-ih.com
11
Agenda | Day One Agenda | Day Two
Tuesday, June 25th Wednesday, June 26th
Pitch Meet-the- One-to-one Pitch Meet-the- One-to-one
Conference Sessions Conference Sessions
Sessions Experts Meetings Sessions Experts Meetings
8:30 am 8:30 am
Name badge pick-up & Welcome coffee 9:00 am
Welcome coffee
9:00 am
ARTOIS 1 ROOM ARTOIS 2 ROOM INNOV’AREA* ARTOIS 1 ROOM INNOV’AREA*
Start-up Slams
Connected devices 9:00 am MedTech and digital industry: Which grounds
9:00 am Faster together:
redesign healthcare: Start-up Slams 10:30 am for collaboration? > Session 3
Which recent trends in
10:30 am How are MedTech Medtech One-to-one
academia-big players
companies adapting to > Session 1
Experts Meetings
collaborations?
this new environment? Flash 10:30 am
meetings
11:00 am
Networking break
10:30 am
11:00 am
Networking break ARTOIS 1 ROOM INNOV’AREA*
Collaborative
EUROTOP ROOM 11:00 am Agnostic investors or pure players in the and Licensing
MedTech sector: Who is becoming prominent in Opportunity
11:00 am Plenary Session: 12:30 pm the early-stage financing scene? Presentations
12:30 pm How to increase the number of > Session 2
MedTech unicorns in Europe? 12:30 pm
2:00 pm
Lunch
12:30 pm Medtech One-to-one
2:00 pm
Lunch Experts Meetings
ARTOIS 1 ROOM ARTOIS 2 ROOM INNOV’AREA*
What are the key Shifting to value-based Flash
ARTOIS 1 ROOM ARTOIS 2 ROOM INNOV’AREA* meetings
2:00 pm factors of success care models: Start-up Slams
How are healthcare Collaborative in the relationship What are the
2:00 pm systems and health and Licensing 3:30 pm between an academic challenges for the > Session 4
Final stretch to MDR/ Opportunity
3:00 pm plans directly institution and a diagnostic tests and
IVDR implementation Presentations
investing in innovative resulting spin-off? technologies ?
companies in Europe? > Session 1
3:30 pm
ARTOIS 1 ROOM ARTOIS 2 ROOM INNOV’AREA* Medtech One-to-one 4:00 pm
Networking break
Experts Meetings
3:00 pm How will moving Start-up Slams Flash INNOV’AREA*
European Public ARTOIS 1 ROOM
toward outcome-based meetings
4:00 pm Procurement and Award
payment models affect > Session 2 How do IT tools contribute to accelerate the
Innovation in MedTech 4:00 pm Ceremony
financing in MedTech? process of completing clinical trials in the
5:30 pm MedTech sector?
4:00 pm
4:30 pm
Networking break
ARTOIS 1 ROOM VAN GOGH 3 ROOM INNOV’AREA*
4:30 pm Big size vs mid-size Service
companies: Different Would-be CEO
6:00 pm Presentations
ways to deal with early- Workshop Track 1: Collaborate to innovate
stage start-ups?
Track 2: Financing innovation
*The INNOV’AREA is located in the
From Technomed Party Track 3: Market innovation exhibition hall.
6:15 pm JEANNE DE FLANDRE ROOFTOP - 11th FLOOR (LILLE GRAND PALAIS)
Track 4: Digital innovation
12 13
Agenda | Hosted Events Agenda | Hosted Events
Tuesday, June 25th Wednesday, June 26th
Peer2Scale Health
Convention Workshop Convention Conference Roundtable Workshop Workshop Conference Workshop Workshop Award Ceremony
ROOMS MATISSE VAN GOGH 3 HAINAUT ARTOIS 2 VAN GOGH 2 HAINAUT ROOMS VAN GOGH 2 ARTOIS 2 HAINAUT VAN GOGH 3 INNOV’AREA
WELCOME
8:30 am COFFEE 8:30 am WELCOME COFFEE
3D-printing of
bioabsorbable drug
9:00 am eluting stents for the Presentation of
9:00 am Mat(t)isse project
treatment of coronary Europe:
artery diseases - Market access
- French
and German Overview of the
Development of a 9:30 am market access upcoming changes
What are the Virtual Testing Platform environments in European
challenges and
9:30 am expectations of for analysis of in vivo - European hubs regulatory
response of 3D printed - Start-ups & SMEs framework for
hospital buyers? coronary artery stents pitches medical devices
10:00 am
In vivo model for the
10:00 am Pitches of start-ups evaluation of drug
supported by eluting stent
Eurasanté, wishing Award Ceremony
to experiment in the 10:30 am NETWORKING BREAK
10:30 am establishment
NETWORKING
10:45 am BREAK
Technical Introducing
NETWORKING 11:00 am 3DMED project What about the
11:00 am BREAK workshop towards Translating Drug-
smart technologies Eluting Contact specific case of - How to raise
for diagnosis Lenses from Bench 3D-printed and entrepreneurship
Feedback of custom-made
11:15 am a successful and treatment of to Practice: Promises Quality control of skills in health
localised cancers and Obstacles 11:20 am 3D printed medical medical devices entrepreneurs?
collaboration (case study)?
between start-ups devices - How Seed teams
11:30 am and establishments are built and
Genetics of strokes how that talent is
11:45 am Pitchs of start-ups Manufacturing 3D retained in start-
supported by 11:40 am printed medical ups?
Eurasanté, wishing devices - How start-ups
A testimony from a define and address
12:00 pm to market their stroke survivor
services Design and Additive market need?
Manufacturing of Questions and
12:30 pm LUNCH 12:00 pm porous titanium answers
implants
Roundtable Digital and Micro
2:00 pm exchange: systems for life
TECH - Part 1
- Scientific and 12:30 pm LUNCH
technical context NETWORKING
3:45 pm - Road to market
One-to-one and opportunity of BREAK
meetings tech transfer
4:15 pm with between
companies and Canada:
4:30 pm hospital buyers - Market access Digital and Micro
- British Columbia systems for life 2:00 pm
- Quebec TECH - Part 2 -
6:00 pm - Ontario
-Pitch sessions of 5:30 pm Conferences
start-ups & SMEs
From
TECHNOMED PARTY (JEANNE DE FLANDRE ROOFTOP - 11TH FLOOR - LILLE GRAND PALAIS)
6:15 pm
14 15
One-to-one meetings
48 hours to meet your future project partners,
obtain funding and accelerate innovation
IDENTIFY INITIATE MEET DEVELOP
today’s innovative discussions with the most qualified new collaborations and
technologies, potential partners, players in the MedTech, partnerships
collaborations investors or clients diagnostic and digital
and licensing health fields
opportunities
JUNE FROM
Who will you meet? 25 th
6.30
L I L L E G RA N D PA L A I S
35% RO O F TO P
MedTech, Room Jeanne de Flandre - 11th floor
Digital health
and Diagnostic
companies
16% 17% NETWORKING
TTOs, COCKTAILS
Suppliers and Research
Subcontractors institutes, ENTERTAINMENT
Academics
DANCING
14% 5%
Professional
and Consulting Investors
services
13%
Clusters,
Associations,
Non-profit
organisations
The partnering platform at MedFIT is powered by:
16 17
Would-be CEO
Are you a MedTech entrepreneur seeking a project?
Do you have projects seeking a CEO?
As talented CEOs are frequently sought-after by many stakeholders of the
medtech industry, to both launch and drive new companies to success, this
Would-be CEO session will bring together representatives of emerging start-
ups, technology transfer offices, incubators and investing networks as well as
CEOs and would-be CEOs to address this important issue.
Any MedTech entrepreneur looking for a project to get involved in is welcome
to join MedFIT and particularly the Would-be CEO session. Any incubator or
tech transfer entity looking for an entrepreneur to lead their start-up projects
is also welcome to join.
June 25th | 4.30 pm - 6.00 pm | Van Gogh 3 Room
Would-be CEO Workshop:
1/ Testimonies from CEOs
How I met my co-entrepreneur
Moderator: Simon Pickard
WIN A FREE PASS FOR
NEXT YEAR’S EDITION
Network Director, Science Business
Stig Visti Andersen
CEO, Magnisense
Bart Geers 2 S T E P S T O P A R T I C I P AT E :
Investment Manager, KU Leuven
1• Take a picture with the 2020 MedFIT Save the Date
2• Post it on Twitter with the hashtag #MedFIT2020
Mike Karim
CEO, Oxford Endovascular
The winner will be announced on June 27th, 2019
2/ Networking time on Twitter and will be contacted by the MedFIT team.
Let’s discuss and network over a drink! This networking moment will be the
occasion to establish collaborations between future entrepreneurs and
projects in need of CEOs.
FOLLOW US ON TWITTER: @MEDFIT_EVENT
18 19Meet-the-Experts The experts
Julien Aldegheri
IEC62366-1: 2015 | MD Design | Ergonomic evaluation
30
Minute
12
MedTech
Blandine Bouvet
Quality management systems | Trainings and audits
Meetings Experts
Laura Charbonnel
Talent management | Recruitment
Mathieu Charleux
Are you seeking assistance from Medical Device Experts? International business development and strategy
Secure a free flash meeting by sending a request on MedFIT’s partnering platform to Myriam Desmet
meet with one of our experts. International expert in regulatory, quality and clinical affairs in the medical
The Experts are specialised in many fields, such as: devices industry
Regulatory affairs / Quality assurance
Production / Sourcing Sebastien Ferret
Preclinical evaluation / Clinical affairs Clinical evaluation | Risk management | Regulatory
Reimbursement strategy | CE-marking
Sales and marketing strategy
Funding and financing Eric Filion
Research & development QA/RA | FDA Clearance | MDSAP | Canada | USA | North America |
Merger and acquisitions Sales support
Human resources
Christine Grasset
How does it work? Product development | Funding innovation
2 options:
Christine Horvais
1/ You already booked a meeting on the partnering platform HR audits | Evaluation interviews | Recruitment in Sales-Marketing-QA-RA-
prior to the event. Clinical studies-R&D-Top management
Go to the MEET THE EXPERTS ZONE for your scheduled
appointment. Cyrille Michaud
Quality insurance | Regulatory affairs | CE/FDA |
2 / You haven’t booked a meeting yet. Software medical device life cycle management
Onsite meeting requests are subjects to availability.
Go to the MEET THE EXPERTS ZONE to see if one of our experts Ahmad Mihyar
is available to assist you. International business development and strategy
Julien Prouteau
QMS ISO13485 | CE-marking | Process validation
Powered by:
20 21Pitch Sessions Agenda | Start-up Slams
The MedFIT pitch sessions offer the opportunity to detect the most innovative and The Start-up Slams are a great opportunity for young companies to showcase their
promising start-ups, R&D projects, licensing opportunities and services in order project in front of potential partners and investors.
to foster partnerships and business developments in the MedTech, diagnostic and The selected candidates will present their project and receive advice and feedback
digital health fields. (“speed-mentoring”) from a panel of experts.
Discover the most innovative start-ups in the following fields:
The winner(s) will be awarded as the most innovative start-up(s)
and the most promising technology(ies) in Europe in MedTech,
June 25th | 9.00 am - 10.30 am | Innov’Area
Diagnostic or Digital Health. Award ceremony:
Wednesday, June 26th from 4:00 pm CARDIOVASCULAR
Innov’Area (exhibition hall)
AORTYX (Innov’Area - IA2)
Aortic disease | Endovascular repair | Regenerative technology
CAIRDAC
Leadless pacemaker | Autonomous power supply | Implantable active medical device
JURY MEMBERS: CARDIACBOOSTER (Innov’Area - IA5)
Alp Akonur, Director Technology Strategy, Baxter Healthcare Cardiac assistdevice | Interventional cardiology | Cardiogenic shock and high-risk PCI
Stig Visti Andersen, CEO, Magnisense
Rajiv Vaid Basaiawmoit, Head of Sci-Tech Innovation & Entrepreneurship, Aarhus University TOURNICARE (Innov’Area - IA1)
Frank Bulens, Partner, Imec.xpand Accurate | User-friendly | Empowerment
Remke Burie, Operations Director, Technical Medical Centre, University of Twente
Ravi Chana, Head of Business Development, Roche Diagnostics VEINSOUND (Innov’Area - IA20)
Alain Chevallier, Partner, Truffle Capital
Varicose | Vein | Hifu
Steven Dodsworth, CEO, D Health
Alexander Hall-Daniels, Operations Associate, RebelBio – SOSV
PARAGATE MEDICAL (Innov’Area - IA17)
Célia Hart, Partner, Supernova Invest
Heart Failure | Fluid Management | Home based care
Ulf Hengstmann, Digital Innovation Manager, Bayer Business Services
Santiago Ini, Technology Transfer and Innovation Advisor, Bio & MedTech Innovation Hub
Brigitte Lavoie, Visiting Fellow, University of Southampton VESSELSENS (Innov’Area - IA21)
Ron Nitzan, Vice-President Quality and Regulatory Affairs, Keystone Heart Implantable monitoring system | Wireless restenosis detection | Electrical passive implants
Nicolas Ploquin, CEO, Unilabs
Régis Roche, General Manager, PMT Microtechnology Cluster WHITESTONEBIO (Innov’Area - IA4)
Asma Serier-Larochette, External Innovation - J&Join Leader & Instigator, Johnson&Johnson Predictivity | Thrombosis | Monitoring
Florent Surugue, Economic Development and SMEs Director, SNITEM
Kyun Thibaut, Managing Director, Covartim PRECIPHOS DIAGNOSTICS (Innov’Area - IA18)
Systemic Diagnostic | Dengue virus | Atherosclerosis
22 23Agenda | Start-up Slams June 26th | 9.00 am - 10.00 am | Innov’Area
DIAGNOSTIC
June 25th | 3.00 pm - 4.00 pm | Innov’Area SEPTEC (Innov’Area - IA3)
Near-patient decision-making | Bloodstream Infection Detection | Companion Diagnostics
AI/BIG DATA
LUMEDIX (Innov’Area - IA11)
AXOMOVE Nanoparticles | Point-of-Care | Ultra-sensitive diagnostics
Self-rehabilitation | Prevention | Exercices
IPDx
CERENION (STAND E2) IVD diagnostics | Big data | Antibodies
Brain monitoring | Intensive care | EEG analysis
CASIS (Innov’Area - IA7) June 26th | 2.00 pm - 3.30 pm | Innov’Area
Cardiovascular imaging | Deep learning | Diagnosis support
MONITORING
MY CYBER ROYAUME (Innov’Area - IA16)
Medical device (CE Label) for neuro-therapist | Dependant people | Virtual reality MOTION CAPTURE GROUP (Innov’Area - IA15)
Motion biomarker | Motion wearables and ml/ai decision support solution | Digital care
GRAPHEAL (Innov’Area - IA9)
Wound healing | E-Health | Diabetis NANOVATION (Innov’Area - IA6)
Remote Respiratory Monitoring | COPD | Wearable Devices
CANCER GABI SMART CARE
MIKROBIYO (Innov’Area - IA13) Predictive medicine | Respiratory Disease | Baby
Liquid Biopsy | Circulating Tumor Cells | Microfluidics
COATING/IMPLANTS/WOUND
June 26th | 9.00 am - 10.00 am | Innov’Area SPARTHA (Innov’Area - IA19)
Antimicrobial agents | Coating | Immunomodulation
GENERIC TOOLS
DIANOSIC (Innov’Area - IA8)
TRANSPLANT BIOMEDICAL Innovative and effective | Mini- invasive and connected | Cost-effectives
Organ preservation | Ultrasound technology | Organ transplantation
ENDOTACT (STAND C6/7)
INNOVGEL (Innov’Area - IA10) Medical Devices | Connected Implantable devices | Artificial Intelligence
Hydrogels for 3D cell culture | Bio-inks for bioprinting | Tissue engineering and
regenerative medicine MOLECULAR PLASMA GROUP (Innov’Area - IA14)
Fast | Single step | Controllable
JETCELL (Innov’Area - IA12)
Eco-friendly | Disposable | Energy PFFI (STAND C6/8)
Back pain | Surgical Instrumentation | Flexibility
PIR2 (STAND B4/5)
Robotics | Interventional radiology | Needle insertion
24 25Agenda | Collaborative and Licensing
Opportunities Presentations
June 25th | 2.00 pm - 3.00 pm | Innov’Area
The Collaborative and Licensing Opportunity Presentations are dedicated to TTOs,
universities, research institutes and companies which have a technology and are willing
to entail a collaborative project and/or a licensing deal. INJECTION / NEEDLE
The selected candidates will present and promote their assets in front of the MedFIT
participants. VERAPIDO DERMAJECT (STAND B1)
Overmolded microcannula | Intradermal injection (immunology, dermatology) |
Discover the most innovative technologies in the following fields: USP: Simulation of the Mantoux injection technique (flat cannula insertion angle)
June 25th | 2.00 pm - 3.00 pm | Innov’Area
CARDIOVASCULAR / NUTRITION June 26th | 11.00 am - 12.30 pm | Innov’Area
SATT LINKSIUM – IPAV DIAGNOSTIC
Coronary atherosclerotic plaque imaging | IVUS-elastography | Coronary artery diseases
EDUCAT (STAND B5)
SATT LINKSIUM – SYMBIOTAENIA Open modular data collection system | Embedded system configuration from Androit
Microbiome | Nutrition control | Disorders tablet | Cloud database
UNIVERSITY OF GREENWICH MIKROBIYO (Innov’Area - IA13)
Bioabsorbable stents | 3D printing | Coronary diseases Differential blood analysis | Impedance-based measurements | Cell characterization
IMAGING PLEXTEK
Wearable | Auditory | Detection
SATT NORD – SIEMPER
MRI compatible probe to determine mechanical properties of pelvic organs | Diagnosis SATT LINSKIUM – SENSIFONG
of pelvic disorders | Simulation of scenarios of childbirth and prolapse procedures Antifungal resistance | Candida | Aspergillus infections
SATT NORD – SPIDERMASS SATT LINKSIUM – ZETAQUANTOR
Molecular Guided Surgery | Tumor Margins & Grading | Real time Diagnosis ZEBRA biomarker | Serological test | Post-transplant lymphoproliferative disorder (PTLD)
26 27Agenda | Service Presentations
The Service Presentations are dedicated to service providers and technology
TECHNOLOGICAL SERVICES
platforms with an innovative offer. LLS ROWIAK
The selected candidates will present and promote their offers in front of the MedFIT LLS ROWIAK LaserLabSolutions GmbH offers advanced histology services performed with
participants, and thus boost their visibility. laser microtomy, in particular for specimen hard to cut with mechanical methods. This affects
in particular the field of regenerative medicine implying histology of bone, teeth, implants,
biomaterials or cardiovascular stents. Complete tissue preparation from fixation, resin embedding,
cutting and staining is performed.
Sponsored by:
BIT GROUP
BIT develops, manufactures and services high performance clinical, medical and life science
NAMSA (STAND C2) devices for clients, allowing them to improve and save lives worldwide. The group’s mission is to
Driven by their regulatory expertise, NAMSA’s MRO® Approach plays an important role in help clients rapidly and efficiently provide innovative and cost-effective products to the market,
translational research, applying a unique combination of disciplines—consulting, preclinical, specifically focusing in the hematology, immunology, molecular, anatomical pathology and
toxicology, microbiology, chemistry, clinical and quality—to move client’s products through clinical chemistry segments.
the development process, and continue to provide support through commercialization to post-
market requirements, anywhere in the world.
COACHING AND CONSULTING
Discover the most innovative offers in the following fields:
EVOLUTION EUROPE
Evolution Europe is a company specialized in helping highly innovative companies in obtaining
June 25 | 4.30 pm - 6.00 pm | Innov’Area
th public funds through European programs (H2020 or other multi/bilateral programmes). Evolution
Europe support SMEs throughout the whole process from identifying the appropriate program
and writing the proposal to carrying out the project management and administrative burden.
IT TOOLS
JA KEMP
Ranked in tier 1 by The Legal 500 and Chambers and Partners, JA Kemp is one of the largest UK and
ITK ENGINEERING GMBH (STAND C7)
European Patent and Trade Mark Attorney firms. The company helps start-ups and university spin-outs
The realization of innovative health care ideas and concepts in marketable medical solutions
or IT-based health services is an extreme challenge for SMEs, Startups and research alliances in to protect their intellectual property through Patents, Trade Marks and other forms of protection.
healthcare industry. From medical apps to secure back-ends and data analytics approved for
clinical studies – the use of software building blocks supports digital health ventures to accelerate iTCH!
market entry for these patient-centric digital health applications. As one specific example, a The solution found by the partnership of the the Interreg VA 2 Seas EDUCAT project was to
personalized, app-based assistance system which supports patients with bipolar disorder will be develop an international digital platform iTCH! The platform enables a broad range of people to
presented. This will show how digital health building blocks can be used and how valuable they are share ideas or contribute experience and skills to different projects. The platform enables a broad
to realize digital healthcare solutions. range of people to share ideas or contribute experience and skills to different projects.
PRYV THE HEALTHTECH TAB
Pryv makes essential software for data-driven healthcare innovation. Our purpose-built The TAB helps any European innovators (i.e. Start-up, SMEs, entrepreneurs, academics, industry)
middleware helps Medtech organizations manage personal data from creation to use, sharing to build successful HealthTech businesses in Europe by providing them with tailored free-of-
and disposal. charge support for their project, thanks to its team of industry experts. It aims to accelerate the
development of emerging medical technologies in Europe.
28 29Conference Programme Plenary Session
Steered by a prestigious Committee, the MedFIT conference programme brings
together bright minds to debate on innovation-focused topics, to foster learning, June 25th | 11.00 am - 12.30 pm | Eurotop Room
inspiration and wonder – and provoke conversations that matter. Over 60 international
experts will discuss current stakes of the sector related to innovative collaboration,
financing, market access and regulation as well as MedTech digitalisation: How to increase the number of MedTech unicorns in
Europe?
Europe is currently benefiting from a dynamic MedTech start-up ecosystem.
Track 1: However, not so many of these start-ups succeed in scaling-up. What are the
Collaborate to innovate possible strategies and paths to get bigger on MedTech market in Europe? What
#Licensing #Partnerships #R&D do we lack in order to accompany the scaling-up of MedTech companies? How
to grow the private equity and stock markets to enable more frequent success
in that process? How to ensure that the development and consolidation of the
sector are also fuelled by MedTech SMEs merger and acquisition deals?
Track 2: Moderator:
Tina Tan
Financing innovation Executive Editor
#VCs #Startups #Investors FirstWord MedTech
Xavier Bertrand
VP Healthcare services &
Alliances EMEA
Boston Scientific
Track 3: Nicolas Durand
Market innovation CEO
Abionic
#Regulation #BusinessModels #Strategy
Martin Frost
CEO
CMR Surgical
Gerard Hascoet
Track 4: Partner
Digital innovation Sofinnova Partners
Executive Chairman
#AI #Data #Transformation MD Start
30 31Trac
k1 Collaborate to innovate
#Licensing #Partnerships #R&D
June 25th | 4.30 pm - 6.00 pm | Artois 1 Room
Big size vs mid-size companies: Moderator:
Ilya Kazi
different ways to deal with early- Partner, Patent Attorney
Mathys & Squire
stage start-ups?
Alp Akonur
Start-ups with new medical technology on the Director Technology Strategy
market are becoming overpriced. Therefore, Baxter Healthcare
large and mid-size companies are showing a
growing interest for earlier stage MedTech Duko Drijfhout
companies through R&D collaboration and Investment Manager
Uniiq
June 25th | 9.00 am - 10.30 am | Artois 2 Room licensing deals when looking outside for new R&D.
Which strategies are those companies pursuing? Ron Nitzan
Faster together: Which recent Moderator:
Anne Blackwood Is there a difference of pattern between big and Vice-President Quality and
trends in academia - big players Chief Executive mid-size companies approaches when dealing Regulatory Affairs
Keystone Heart
Health Enterprise East with early stage investment and assets?
collaborations?
Seamus Browne
The shifting MedTech landscape has led big Head of Industry Partnerships
industry players to seek new collaborations to Royal College of Surgeons in Ireland
support their R&D needs rather than in-house June 26th | 2.00 pm - 3.30 pm | Artois 1 Room
efforts, initiating fresh ways to partner with Perry Frederick
Senior Director for Strategic Research
academic institutions and speeding-up market GE Healthcare What are the key factors of success Moderator:
Thomas Meier
access. On which needs are these collaborations in the relationship between an Managing Director
focusing and what are the main reasons driving David Murray you-can.biz
big players to partner with academia? To what Senior Research Engineer academic institution and a resulting
extent are academia and industry developing Cook Medical spin-off? Franz Bozsak
common frameworks, protocols and processes CEO
Terry Parlett Networking opportunities, use of laboratories Sensome
to enable efficient collaboration? Commercialisation Director
Cambrige Enterprise and research cooperation are key resources
Frank Bulens
universities can provide to their spin-offs in their Partner
further development. How can these ventures Imec.xpand
make their academic institution of origin a long-
term partner? Which benefits do universities Santiago Ini
have when continuing to provide the start-up Technology Transfer & Innovation Advisor
with the support required? Are there some ideal Bio & MedTech Innovation Hub
routines and guidelines to create a profitable
Brigitte Lavoie
and long-lasting collaboration for both? Visiting Fellow
University of Southampton
CEO, Afin
32 33Trac
k2 Financing Innovation
#VCs #Startups #Investors
June 25th | 3.00 pm - 4.00 pm | Artois 2 Room
How will moving toward outcome- Moderator:
Stefan Suter
based payment models affect Founder & CEO
Curo-Health
financing in MedTech?
Lili Brillstein
Moving toward value-based care models, MedTech Director, Episodes of Care
companies have seen increasing price pressures and Horizon Blue Cross Blue Shield of New
the necessity to improve patient outcomes. When it Jersey
comes to demonstrate the improvements in patient
outcomes, it may prove longer for a company to Robbie Hughes
CEO
June 25 | 2.00 pm - 3.00 pm | Artois 1 Room
th
see significant financial return. How are the new Lumeon
outcome-based payment models changing the way
How are healthcare systems and Moderator:
Frédéric Nouaille innovation is perceived? How is quality measured Gregory Katz
health plans directly investing in Co-Founder & Partner and how are investment criteria evolving? Who President
Consortium VBHC France
Audit&Risk Solutions
innovative companies in Europe? takes on risk in a value-based care model? How to
ensure improved communication within the payers‘
Sandrine Coulange
Healthcare systems and health plans have been Health Programme Director community to ease funding and reimbursement?
a growing source of innovation investment and Axa Next
their interest in financing start-up companies
and new technologies appears to be at its Tsafrir Kolatt
CEO June 26th | 11.00 am - 12.30 pm | Artois 1 Room
peak. Facing a twofold challenge to improve Fertigo-medical
patient care while cutting costs, which assets are Agnostic investors or pure players Moderator:
Alex Hall-Daniels
healthcare systems and health plans targeting? Arjun Panesar in the MedTech sector: Who is Operations Associate
Is this ad-hoc innovation investment or can Co-Founder & CEO RebelBio – SOSV
we observe more permanent and strategic Diabetes Digital Media becoming prominent in the early-
approaches? stage financing scene? Alain Chevallier
Joop Tanis Partner
Director MedTech Consulting and Seed and Series A investments are critical to Truffle Capital
Business Development
Health Enterprise East transforming new ideas into products and moving
Mike Karim
start-up teams into small businesses. From CEO
investors with a varied degree of specialisation Oxford Endovascular
to totally agnostic players only focusing on
MedTech, who are the main players at these Rajan Patel
financing stages? What is the significance of CEO
iO Life Ventures
the amount of early-stage investment today
for cross-industry funds, specialised healthcare Josep Sanfeliu
funds and pure players in the MedTech industry CEO
respectively? Asabys Partners
34 35Trac June 25th | 3.00 pm - 4.00 pm | Artois 1 Room
k3 Market Innovation
#Regulation #BusinessModels
European Public Procurement and
Innovation in MedTech: What are
the strategies and best practices to
Moderator:
Frank Weber
Co-creation Entrepreneur
HealthCareCoCreation
#Strategy facilitate purchasing and adoption of Yolanda Puiggròs Jiménez de Anta
Partner, Healthcare & Life Sciences
innovative medical technologies? Roca Junyent
A large part of Europe’s medical technologies are Ole Ravnholt Sorensen
purchased using procurement processes. EU’s 2014 Senior Policy Consultant
Public Procurement Directives introduced a number Danish Regions
of changes in the European legal framework, including
June 25th | 2.00 pm - 3.00 pm | Artois 2 Room a focus on the role of public procurement in achieving Jean-Luc Sanne
Moderator: Senior Expert, Research and Innovation
Final stretch to MDR/IVDR Elena Kyriacou innovationaswellasgood-practiceexamplesonreducing European Commission
implementation: Founder, Elemed administrative procedures, adjusting selection criteria,
Moderator, EU MDR/IVDR mobilising innovation brokers and designing an SME-
Linkedin Community
How are companies revising their friendly payment scheme to better attract innovators to
strategy to comply with the key Juliette Cook public procurement. This roundtable discussion will bring
Regional Regulatory Director EMEA together public institutions, policymakers and innovative
requirements and associated Cochlear companies to provide a comprehensive overview of
timelines? Corinne Delorme
initiatives and good practices to foster and support public
Global head of Regulatory Affairs procurement of innovations.
EU new regulations are introducing an enhanced GMED
framework around the definition, supervision,
traceability and risk-based classification system Laurence Matheron June 26th | 2.00 pm - 3.30 pm | Artois 2 Room
for medical device equipment. They will shortly Director Regulatory Services, IVDs and Moderator:
apply after a transitional period: May 2020 Medical Devices Shifting to value-based care models: Robyn Meurant
Executive Director, Regulatory
for the medical devices and May 2022 for in-
NSF International Health Sciences
What are the challenges for the Team, IVDs and Medical Devices
vitro diagnostic medical devices. How has the
Carole Robin
diagnostic tests and technologies? NSF International Health
Sciences
upcoming deadline impacted the MedTech and Director, Regulatory Affairs Ravi Chana
diagnostic players both from a European point Thuasne As health systems worldwide move from treatment Head of Business Development
of view and for foreign companies conducting to prevention, and from volume-based to value- Roche Diagnostics
business in Europe? What long term implications based care model, diagnostics can deliver significant
may this new legislation have on innovation improvements eased by the huge opportunities Senan Doyle
and market investment? How are companies Co-Founder & CEO
offered by digitalisation. As diagnostic services are Pixyl
and regulatory authorities dealing with the a pivotal stage in patient care, early diagnosis can
remaining uncertainties? increase the probabilities of a positive outcome for Philippe Grandjean
patients and save costs of further treatment. How Executive Vice President Commercial Operations
are the diagnostic providers aligning with value- BIT Group
based care? From diagnostic imaging to companion
diagnostics, this panel discussion will explore the key Alexis Hernot
Co-Founder & CEO
challenges and share best practices for this strategic Calmedica
industry of the shifting healthcare system.
36 37Trac June 26th | 9.00 am - 10.30 am | Artois 1 Room
k4 Digital Innovation
#AI #Data #Transformation
MedTech & digital industry: Which
grounds for collaboration?
Moderator:
Steven Dodsworth
CEO
D Health
The MedTech sector has been subject to a
substantial transformation during the past Dan Akarca
Research Fellow
decade due to the arrival of new digital Medicalchain
technologies. The sector is now facing a growing
inspiration from digital disrupters and tech Meriem Benmelouka
giants expanding their healthcare reach through Global Business Development Manager
Roche Diabetes Care
mergers and acquisitions. As more collaboration
and integration across companies and sectors Tom Braekeleirs
June 25th | 9.00 am - 10.30 am | Artois 1 Room will be a vital part of the next wave of innovation, Director
what are the recent trends in jointly developing BlueHealth Innovation Center
Moderator: supported by Microsoft
Connected devices redesign Frederic Lievens
cutting-edge medical devices technologies.
To what extent are MedTech and digital industry
healthcare: How are MedTech Vice Executive Director
International Society for working together to deliver new products and Jan Pensaert
companies adapting to this new Telemedicine & eHealth services for patients? Which collaboratives
Founder & Managing Partner
Valiance
environment? Alex Bone models are emerging? What are the successful
Partner, Patent Attorney examples and the limits to these collaborations?
Digital health technology and services are fastly AA Thornton
growing, offering a wide new range of connected
Ulf Hengstmann
devices, transforming and personalising the Digital Innovation Manager June 26th | 4.00 pm - 5.30 pm | Artois 1 Room
way care is delivered. Information and data Bayer Business Services
Moderator:
generated by medical technologies, paired How do IT tools contribute to Silvia Casellas
with the advances in AI should play a vital role in John E. Milad
improving health outcomes and making health CEO accelerate the process of completing Director of Clinical
Research & CEO
systems more efficient. How are innovative
Quanta Dialysis Technologies clinical trials in the MedTech sector? Anagram
companies, large and small, adapting their Jean Nehme Clinical data and evaluation of that clinical data Christophe Amiel
business models? How do they deal with the Co-Founder & CEO Senior Director, Medical Devices &
flow of data and the legal and regulatory related Touch Surgery is an explicitly defined legal requirement for Digital Life Sciences
issues? medical devices. Solutions to fast-track market Voisin Consulting Life Sciences
access may emerge from wearables and data
analytics programs and allow a stronger and more Barbara D’haene
CEO
efficient patient engagement and monitoring. Akcelis
What impact and scalability these IT solutions
have on the medical devices clinical trial design? Elie Lobel
How are they integrated in the market access CEO
strategies of the MedTech players? Orange Healthcare
Aly Talen
Co-Founder & Senior Vice President
Business Development
Genae
38 39Notes Notes 40 41
Hosted Events
SMARTHEALTH AWARD CEREMONY
EIT HEALTH GO GLOBAL TRACK: June 26th, 2019 | 10:00 am Innov’Area (wihtin the exhibition area)
CANADA and EUROPE market access conferences – meet the local players!
EIT Health is the largest healthcare innovation community in the world, federating a consortium
of more than 50 core partners and 90 associate partners from leading businesses, research
centres and universities from across 14 EU countries. As part of its Accelerator activities, EIT
Health provides internationalisation support programmes for SMEs working in the medtech,
biotech and digital health sectors called GoGlobal.
Since 2018, a GoGlobal activity is being run with CANADA and provides a unique gateway to the SmartHealth is a 2-year cross-border project developed by 4 experienced innovation
main innovation hubs of the Montreal, Toronto and Vancouver regions. agencies and clusters across UK and France: SEHTA, EPM, Amiens Cluster and Eurasanté. It
is committed to the design and delivery of innovative support services to meet the needs of
The two conferences:
health and care organizations. Its aim is to organize a contest rewarding pairs of French and
• Deliver high level contents on access to market strategy and recommendations for
British SMEs by offering them an opportunity to meet and resolve care organizations’ digital
start-ups and SMEs willing to investigate in Canada or Europe
problematics.
• Give valuable insights into the innovative trends, initiatives and ecosystems across
Canada and Europe.
The first round of the SmartHealth contest was launched at the Kick Off Meeting on
• Be a great opportunity to network, share experience and meet key stakeholders that
February 5th 2019 and closed on April 30th 2019. It is now time to announce the laureates
can help SMEs in their long-term development plan towards these two markets.
and to present the Support Program they will access to !
CANADA | June 25th from 4.30 pm – 6.00 pm Artois 2 Room
• Accessing the Canadian market for European medtech SMEs: opportunities and recommendations, Where? Innov’Area (within the exhibition area)
update on MDSAP program and way forward | Eric Filion – LOK NORTH AMERICA
• Overview of the trends and opportunities in British Columbia | Laetitia McDougall – Government of British Speakers:
Columbia
• Overview of the trends and opportunities in Quebec | Sabrina Fettal – MEDTEQ • Etienne Vervaecke - Managing Director, Eurasanté: Introduction of the SmartHealth
• Overview of the trends and opportunities in Ontario | Ying Tram– MaRS Ventures Interreg Project.
• Zoom on TECHNA model of innovation | Luke Brzozowski - TECHNA and Diagnostics Innovation • Julie Follet - e-Health Project Manager, Amiens Cluster: Introduction of the hospitals
• Showcasing Canadian innovation / pitch session of 5 start-ups & SMEs
• Intellijoint Surgical Inc ☺- Toronto // ON involved into the contest and the SmartHealth Support Program for selected SME.
• Maple Corporation - Toronto // ON • David Parry - CEO, SEHTA: Announcement of the laureates of the first wave and
• Mespere LifeSciences - Waterloo // ON launching of the next wave of application.
• MetaOptima Technology INC - Vancouver // BC
• Puzzle Medical Devices Inc - Montreal // QB Partners:
EUROPE | June 26th from 9:00 am – 10:30 am Artois 2 Room
• Accessing European markets through EIT HEALTH | Olivier Fontaine - Medicen Paris Region
• Becoming relevant in Europe | Thomas Meier, You-Can Biz
• Update on European regulation for medical devices & Neighborhood initiative | Christophe Amiel &
Sébastien Giraudier - Voisin Consulting Life Sciences
• Understanding the French healthcare system and market access | Sylvia Germain - SGE Consulting This project is co-financed by the European Regional Development Fund
• Understanding the German healthcare system and market access | Dr. Madeleine Kuenz - Kalms Consulting
• Understanding the Spanish healthcare system and market access | Meike Bomhof - Hull Associates
Partners:
42 43Hosted Events COBRA TECHNICAL WORKSHOP
Towards smart technologies for diagnosis and treatment of localised cancers
IMODE THIRD ANNUAL CONVENTION June 25th, 2019 | 10:30 am - 12:00 pm Van Gogh 3 Room
June 25 , 2019 | 8:30 am - 12:30 pm Hainaut Room
th
IMODE is a collaborative research project for multicomponent pharmaceutical
products (co-amorphous and co-crystals) and medical devices that are loaded with Technological innovation for biopsy and brachytherapy under MRI control, in order to
bioactive molecules. Started in 2016, the project’s overall objective is to bring together
the specific transdisciplinary skills and experiences of partners (academic research improve diagnosis and treatment of localised cancers
groups, development agencies, SMEs) in order to provide the 2 Seas Area with strategic The CoBra project aims to improve the quality of both diagnosis and treatment of localised
advantages for innovative pharmaceutical and medical applications. cancers, by developing a new medical robot prototype for brachytherapy and biopsy under
IMODE is organising its third annual convention during MedFIT with a morning
conference on June 25th. IMODE will also hold a stand during MedFIT convention and guidance of MRI. The overall objectives of the project is to improve the accuracy of cancer
participate to MedFIT one-to-one meetings. diagnosis, and to increase the accuracy of treatment, increasing cure rates and minimising side
effects. The prostate and other soft tissues will be the main localised cancers of interest in the
Programme: Cobra project.
8:30 am – 9:00 am | Name badge pickup and Welcome coffee CoBra – Technical Workshop on Brachytherapy is hold during MedFIT with a morning
9:00 am – 9:30 am | 3D-printing of bioabsorbable drug eluting stents for the treatment of coronary conference on June 25th. CoBra is also holding a stand during MedFIT convention and
artery diseases – The magic disappearing stents participate to MedFIT one-to-one meetings.
Pr. Dennis Douroumis, University of Greenwich, Faculty of Engineering and Science The round table is composed of doctors, industrials and led by the leader of the CoBra project.
Discussions will focus on opening up innovative technology for diagnosis and treatment of
09:30 am – 10:00 am | Development of a Virtual Testing Platform for analysis of in vivo response of cancers. Professor Rochdi Merzouki leads the round table and will begin with a presentation of
3D printed coronary artery stents.
Dr. Michael Okereke, University of Greenwich, Faculty of Engineering and Science
the CoBra project and its progress.
List of experts speakers:
10:00 am – 10:30 am | In vivo model for the evaluation of drug eluting stent • Prof. Rochdi Merzouki – Professor Robotics & Mechatronics / CoBra Project leader
MD Justine Mougin, University of Lille, UMET Laboratory CRIStAL-UMR CNRS 9189 / University of Lille
10:30 am – 11:00 am | Networking break • Prof. Jean-Pierre Pruvo – University professor and hospital practitioner (PU PH) / Head of
Neuroradiology Department
11:00 am – 11:30 am | Translating Drug-Eluting Contact Lenses from Bench to Practice: Promises and Lille University Hospital
Obstacles • Dr. Maximilien Vermandel – Associate Professor / Medical Physicist
Dr Sheng Qi, University of East Anglia Inserm OncoThai / University of Lille / Lille University Hospital
• Dr. Christophe Szymanski – Surgeon / Hospital practitioner Orthopedic department
11:30 am – 12:00 pm | Genetics of strokes Lille University Hospital
Pr. Sharma Pankaj, Ashford and St Peter’s Hospital’s NHS Foundation Trust • Dr. Klaus Düring – Chief Executive Officer
MaRVis Interventional
12:00 pm – 12:30 pm | A testimony from a stroke survivor: I am not afraid of storms for I am learning • Dr. Rutger Fick – Lead Optimization Architect
to sail my ship TheraPanacea
Satinder Faulkner, UK • Dr. Jérôme Benoit – Veterinary Radiation Oncologist
Oncovet
12:30 pm – 2:00 pm | Lunch
Partners & observers: cobra-2seas.eu
1:00 pm – 6:00 pm | Access to MedFIT and one-to-one meetings
Partners: project-imode.com Contributing to saving lives
This project is co-financed by the European Regional Development Fund This project is co-financed by the European Regional Development Fund 45Hosted Events
DERMA, OPPORTUNITY FOR TECH TRANSFER OF GHT (REGIONAL HOSPITAL CONSORTIUM) BUSINESS CONVENTION
TWO INNOVATIVE WOUND DRESSINGS PURCHASE & EXPERIMENTATION
June 25th, 2019 | 2:00 pm - 4:30 pm Van Gogh 2 Room June 25th, 2019 | 9:30 am - 6:00 pm Matisse Room
DERMA
Europen Regional Development Fund
Discover the European project DERMA during MedFIT on June 25th during a roundtable
exchange:
• Scientific and Technical context - Dr. Iain Allan, Principal Research Fellow, Meet the purchasing managers of hospital buyers Hauts-de-France and find new
University of Brighton business opportunities.
• Road to market and opportunity of tech transfer - Charles Sanson, Innovation
Manager and Tech Transfer Officer, Eurasanté As part of MedFIT, Clubster Santé, in partnership with Eurasanté, is organising an event
where the hospital buyers from the Hauts-de-France region, the start-ups supported by
Eurasanté, and the member companies of the Clubster Santé network will meet. For the
DERMA, an Interreg 2 Seas project, aims to develop new interventions for the management hospital buyers, these meetings are an opportunity to respond to the daily problems
and treatment of dermal ulcers and related skin conditions, including stomas. By and to bring innovation into their services. For start-ups, this is a privileged moment to
addressing market and patient need, the project will deliver advanced new technologies ready experiment with their concept within an establishment or to prospect for an upcoming
for exploitation by industry to manufacture improved products for the treatment of patients. commercialisation, and thus forge new partnerships. For companies, members of the
Clubster Santé network, it is a real opportunity to meet the needs of institutions and
Challenge: By 2025 more than 25% of Europeans will be 65 or older, a vulnerable group in develop their business
relation to illness. This is a cross-border phenomenon that will challenge healthcare providers.
Ulceration of the extremities of this group is a major societal challenge. Moreover the presence Programme:
of diabetes, cardiovascular diseases, fungating tumours and long-term immobilization, exposes
all age groups to dermal ulceration. To tackle effectively this growing issue, new improved 9:30 am – 10:00 am | What are the challenges and expectations of hospital buyers?
technologies and management options to reduce costs and improve outcomes are needed.
10:00 am – 10:45 am | Pitches of start-ups supported by Eurasanté, wishing to experiment in the
Objectives: The main scientific objectives of DERMA are to design, develop and evaluate an establishment
odour-absorbing, antimicrobial wound dressing and a dressing with diagnostic capability to
10:45 am – 11:15 am | Networking break
indicate wound status.
Partners: 11:15 am – 11:45 am | Feedback of a successful collaboration between start-up and establishment
11:45 am – 12:30 pm | Pitches of start-ups supported by Eurasanté, wishing to market their services
12:30 pm – 2:00 pm | Lunch
2:00 pm – 6:00 pm | One-to-one meetings between companies and hospital buyers
This project is co-financed by the European Regional Development Fund derma2seas.eu
Only members of Clubster Santé can access the GHT business convention.
46 47You can also read
